NOTICIAS

Disponíveis FAQ sobre o novo Regulamento de Dispositivos Médicos

Disponíveis FAQ sobre o novo Regulamento de Dispositivos Médicos

O site do Infarmed disponibiliza, agora, um conjunto de “perguntas frequentes” sobre o novo Regulamento de Dispositivos Médicos. Organizadas por capítulos, pretendem apoiar os diferentes intervenientes deste setor na aplicação do Regulamento (UE) 2017/745, do...

Utilização de canábis e seus derivados em produtos cosméticos

Utilização de canábis e seus derivados em produtos cosméticos

Publicado no site INFARMED 14 fev 2022 1. Enquadramento geral A canábis é classificada no território nacional como estupefaciente, encontrando-se incluída na tabela I-C, anexa ao Decreto-Lei n.º 15/93, de 22 de janeiro, na sua atual redação. No âmbito deste...

Generating high-quality evidence from registry-based studies

Generating high-quality evidence from registry-based studies

PUBLISHED BY EMA News 26/10/2021 EMA has published guidance to provide key methods and good regulatory practices to pharmaceutical organisations on the planning and conduct of registry-based studies. A patient registry is an organised system that collects uniform data...

A stronger role for EMA

A stronger role for EMA

Published by EMA News 31/01/2022 https://www.ema.europa.eu/en/news/stronger-role-ema The regulation reinforcing EMA’s role in crisis preparedness and management for medicinal products and medical devices has been published today in the Official Journal of the EU. This...

Innovative Health Initiative

Innovative Health Initiative

On 23 February 2021, the European Commission published a proposal for a Single Basic Act (SBA) establishing a number of joint undertakings under Horizon Europe, including the Innovative Health Initiative (IHI). The Council adopted the regulation on 19 November 2021...

EMA launches the Regulatory Science Research Needs initiative

EMA launches the Regulatory Science Research Needs initiative

 BY EMA News 15/12/2021 For the first time, EMA has issued a  list of regulatory science topics that need further research to close gaps and improve medicine development and evaluation to enable access to innovative medicines for patients. EMA has identified around...

FDA final guidance on CMC postapproval changes for annual reports

This guidance provides recommendations to holders of biologics license applications (BLAs) for specified biological products regarding the types of changes to an approved BLA to be documented in an annual report under 21 CFR 601.12. Specifically, the guidance...

A vision for use of real-world evidence in EU medicines regulation

A vision for use of real-world evidence in EU medicines regulation

PUBLISHED BY EMA News 24/11/2021 Enabling the use of real-world evidence (RWE) and establishing its value for regulatory decision-making on the development, authorisation and supervision of medicines in Europe by 2025: this is the vision of European regulators as...

EU NEWS : UDI/DEVICES USER GUIDE

EU NEWS : UDI/DEVICES USER GUIDE

The new MDR 2017/745 and IVDR 2017/746 EU regulations introduce an EU identification system for medical devices based on a Unique Device Identifier (UDI) and require that manufacturers of medical devices submit the UDI/Device information of all devices/products that...

Novas creditações para as próximas formações de novembro e dezembro

Novas creditações para as próximas formações de novembro e dezembro

As seguintes formações contam com a  acreditação pela Ordem dos Farmacêuticos   Rotulagem, Packaging e Publicidade de DISPOSITIVOS MÉDICOS3  3 de dezembro de 2021 0.7 CDP (00343/11/2021) PESSOA RESPONSÁVEL de DISPOSITIVOS MÉDICOS 24 de novembro de  de 2021 0.7...

Generating high-quality evidence from registry-based studies

Generating high-quality evidence from registry-based studies

News 26/10/2021 EMA has published guidance to provide key methods and good regulatory practices to pharmaceutical organisations on the planning and conduct of registry-based studies. A patient registry is an organised system that collects uniform data over time on...